

Boldelab-200 is a derivative of testosterone with similar androgenic activity and higher mytrophic activity. Boldelab-200 does not convert into estrogens and does not have estrogen-related side effects. Instead, Boldelab-200 is converted by 5-alpha-reductase into dihydroboldenone and some of it's androgenic effect mediated by dihydroboldenone.
Boldelab-200 increases overall body metabolism rate and increases appetite. Increase in lean body mass and low side effects make this anabolic/androgenic steroid (AAS) a good therapeutic choice for age-related non-genomic muscle degenerative diseases like sarcopenia. The undecylenate ester extends half-life of boldenone in circulation, which, depending on dose, is approximately seven days.
Please log in to write Boldelab-200 review.
Drug Class: Androgen; Anabolic Steroid
Active Substance: Boldenone Undecylenate
Strength: 300 mg/mL
Amount: 10 mL Vial
Active Life: 14–16 days
Average Dose: 300–600 mg per week
Liver Toxicity: Low
Aromatization Rate: Low to Moderate
Anabolic Rate: 100
Androgenic Rate: 50
Manufacturer: Kalpa Pharmaceuticals
Drug Class: Anabolic Androgenic Steroid (AAS), Androgen Ester
Active Substance: Boldenone Undecylenate
Strength: 300 mg/mL
Amount: 10 mL Vial
Active Life: 14–16 days
Average Dose: 300–600 mg/week
Liver Toxicity: None
Aromatization Rate: Low
Anabolic Rate: 100%
Androgenic Rate: 50%
Manufacturer: Dragon Pharma
Drug Class: Anabolic Androgenic Steroid (AAS), Androgen Ester
Active Substance: Boldenone Undecylenate
Strength: 500 mg/mL
Amount: 10 mL Vial
Active Life: 14–16 days
Average Dose: 250–500 mg/week (split dose due to concentration)
Liver Toxicity: None
Aromatization Rate: Low
Anabolic Rate: 100%
Androgenic Rate: 50%
Manufacturer: Dragon Pharma